Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IN-A002 Ointment in Healthy Volunteers and Mild to Moderate Atopic Dermatitis
NCT05729074Phase 1Completed
- Sponsor
- HK inno.N Corporation
- Start
- Feb 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of CJ-15314 in atopic dermatitis (AD) (11 arms), sponsored by HK inno.N Corporation. Primary endpoints: Adverse event at Day 40, Physical examination at Day 40 and 7 more. Started Feb 2023; status: completed.
02
Drugs
CJ-15314
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT05729074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05729074.